Article Details

Neurocrine Biosciences (NASDAQ:NBIX) Upgraded to "Overweight" by Barclays

Retrieved on: 2021-05-12 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

Neurocrine Biosciences (NASDAQ:NBIX) Upgraded to "Overweight" by Barclays. View article details on hiswai:

Excerpt

Acadian Asset Management LLC now owns 4,598 shares of the company's stock valued at $447,000 after acquiring an additional 3,618 shares during ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up